Metagenomi is a pioneering brand in the field of metagenomics, specializing in gene editing systems. With a team of experts led by co-founders Brian C. Thomas and Jill Banfield, Metagenomi has developed the largest and most diverse toolbox of gene editing systems through their cutting-edge technologies and therapeutic programs.

Unlike other gene editing therapies that rely on a single enzymatic technology, Metagenomi takes inspiration from nature and explores the unique characteristics of a wide range of organisms. By harnessing naturally evolved enzymes, they unlock the immense potential of gene editing. Their relentless curiosity and expertise allow them to expand options in human gene editing for therapeutics.

Furthermore, Metagenomi actively seeks partnerships with industry experts to advance their proprietary lead technologies and therapeutic programs. With their headquarters in Emeryville, California, they are at the forefront of revolutionizing gene editing for the betterment of humanity